News

Quantum Rise's AI Webinar: Transforming Media & Advertising

Quantum Rise's AI Webinar: Transforming Media & Advertising

Discover the Future of Media with AI Insights

Quantum Rise, an innovative AI consultancy, is set to host an exciting webinar titled Adapt or Disrupt: Media Leaders on Staying Ahead in an AI Era. This exclusive event promises to gather some of the leading figures in the industry to discuss the transformative effect of AI in the media and advertising landscape.

Panel of Experts Shaping AI Strategies

In an era where digital innovation moves at lightning speed, Quantum Rise is bringing together a distinguished panel of executives to share their insights. Among the speakers is Alex Kelleher, the Founder and CEO of Quantum Rise, known for his pioneering work in AI-driven solutions. Joining him are prominent figures like David Solomon, the CEO of Viamedia, Kate Watts, CEO of 50,000feet, and Jeff Reine, an experienced independent media consultant. These industry leaders will share their knowledge of leveraging AI for business growth.

Alex Kelleher

As the mastermind behind Quantum Rise, Alex Kelleher has led multiple AI initiatives and consulting firms, tailoring AI strategies to drive business success. His approach blends human creativity with cutting-edge machine intelligence, positioning companies to thrive in a competitive market.

Kate Watts

With her extensive experience in branding and business transformation at 50,000feet, Kate Watts emphasizes the importance of understanding audience connections. Her innovative strategies utilize AI to enhance brand engagement and foster long-term loyalty.

Understanding AI's Role in Media

The rapid evolution of artificial intelligence is reshaping how businesses operate. During the webinar, attendees will hear firsthand how AI is revolutionizing the media landscape. The panel will cover topics such as practical AI applications, ethical considerations, and the balance between innovation and consumer privacy.

David Solomon

Leading Viamedia, David Solomon brings over three decades of experience in the advertising industry. Through his leadership, Viamedia has adopted AI seamlessly into its operations, enhancing advertising efficiencies and customer satisfaction.

Jeff Reine

Jeff Reine’s background in digital media spans a breadth of companies and roles, ensuring valuable insights into navigating the rapidly changing digital space. As an independent consultant, he provides strategic advice on embracing innovation while remaining customer-centric.

The Importance of Participation

Attending this webinar is crucial for anyone interested in understanding the evolving media landscape. Participants can expect actionable insights on various topics, including:

  • AI as a Strategic Advantage: Discover how AI enables companies to innovate and stay competitive in their fields.
  • Real-World Applications: Gain insights from successful use cases in the media industry from experts leading the charge.
  • Ethics and Privacy: Explore how to implement AI strategies that respect consumer privacy while driving growth.

Registering for the Webinar

The webinar is free, but registration is necessary to secure a spot. Participants can easily sign up to engage with thought leaders and discover new opportunities brought about by AI in the media sector.

About Quantum Rise

Founded in 2024 and backed by Erie Street Growth Partners, Quantum Rise aims to empower organizations by harnessing the full potential of AI and automation. Their Consulting 2.0 approach focuses on delivering impactful solutions that drive revenue growth and efficiencies. By prioritizing innovative strategies, Quantum Rise continues to position businesses for future success in an AI-driven world.

Frequently Asked Questions

What is the focus of the Quantum Rise webinar?

The webinar will focus on how industry leaders are using AI to transform the media and advertising sectors.

Who are the featured speakers in the webinar?

Key speakers include Alex Kelleher, David Solomon, Kate Watts, and Jeff Reine, all of whom have significant expertise in the media and AI fields.

How can I register for the webinar?

Registration can be done online, and it's free. Make sure to sign up in advance to participate.

What topics will be covered in the webinar?

The panel will discuss AI’s strategic advantages, practical insights from industry leaders, and balancing innovation with privacy.

When will the webinar take place?

The webinar is scheduled to occur at 10:00 AM PT on January 22, 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Molina Healthcare: Anticipating Earnings and Market Movements

Updated Category News Views 138

Molina Healthcare's Upcoming Earnings Announcement Molina Healthcare (NYSE: MOH) is on the verge of releasing its quarterly earnings report, and investors are on high alert. The anticipated announcement will unfold on a Wednesday in the near future, and expectations are building around the company's performance. Understanding Earnings Expectations Analysts have projected...

Continue Reading
Innovative Sportswear Design Award by ANTA and Tsinghua University

Updated Category News Views 121

Introducing the 3rd Global Sportswear Design Award On an inspiring day in June, the 3rd Global Sportswear Design Award kicked off, marking a significant milestone in the world of sportswear design. This prestigious event, held at the China National Silk Museum, is a collaboration between ANTA Group and Tsinghua University. The central theme for this year's award is...

Continue Reading
Boeing's Speculation: What Lies Ahead for Its Stock?

Updated Category News Views 189

Understanding Boeing's Recent Stock Decline Boeing Company (NYSE: BA) shares experienced a noticeable drop recently. This decline followed a significant directive from the Federal Trade Commission (FTC) that requires Boeing to divest a considerable portion of its assets linked to Spirit Aerosystems Holdings, Inc. (NYSE: SPR). The market responded quickly, reflecting...

Continue Reading
Commitment to Recovery: Resilience in the Face of Disasters

Updated Category News Views 194

A Commitment to Community Resilience In recent times, our world has witnessed unprecedented weather events that remind us of the importance of community and resilient governance. Following a rare and intense rainfall that devastated many areas, community members are on the road to recovery, showcasing hope and togetherness. Devastation and Hope in Hard-Hit Regions In one...

Continue Reading
Eledon Pharmaceuticals Advances Tegoprubart for Kidney Care

Updated Category News Views 226

Exciting Advances in Kidney Transplant Rejection Prevention Recent findings from Eledon Pharmaceuticals, Inc. showcase significant results from the Phase 2 BESTOW trial, where Tegoprubart has emerged as a promising contender for preventing rejection in kidney transplant patients. Patients who continued on Tegoprubart for a year post-transplant revealed an impressive...

Continue Reading